Course Title: CE Workshop 01 - Before the Cure: Cognitive Rehabilitation for Mild Cognitive Impairment (Stringer/Hampstead/Larsen)
Credit Hours: 3
Instructor(s) Anthony Y. Stringer; Benjamin M. Hampstead; Margo Adams Larsen
CE Workshop # 1:
Before the Cure: Cognitive Rehabilitation for Mild Cognitive Impairment
Abstract & Learning Objectives:
Dementia is the major cause of disability in older individuals. The worldwide prevalence of dementia is predicted to reach 115.4 million people by the year 2050. Alzheimer’s Disease (AD) is the etiology in 50-70% of dementia cases, and cerebrovascular disease accounts for another 20% of cases, with at least 22% of patients having a mixture of AD and cerebrovascular pathology. Over 400 clinical trials directed at AD are registered in the ClinicalTrials.gov database, with a third of them focused on alleviating cognitive symptoms through pharmacological intervention. Collectively, these studies have a stunning 99.6% failure rate. The overwhelming failure of these pharmacological clinical trials aimed at later stages of dementia has directed attention to the less severe, prodromal syndrome termed Mild Cognitive Impairment (MCI). Additionally, there is growing recognition that non-pharmacologic approaches may both improve cognition and delay conversion to a more severe clinical state. This workshop will focus on evidence supporting non-pharmacological, cognition-oriented treatments in patients with MCI. We will summarize critical methodological factors that may affect the nature and quality of evidence in this area. We will then review the available rehabilitation strategies for MCI and identify treatment resources for clinicians wishing to introduce these interventions into their practice. Data supporting/refuting the neuropsychological and neurophysiological effects (e.g., via functional neuroimaging) of MCI rehabilitation will be presented throughout. The session will close with a survey of the next generation of neuropsychological treatments, including concurrent neuromodulation, virtual reality interventions, and mobile phone applications, for this currently incurable neurological condition.
Upon conclusion of this course, learners will be able to:
- Analyse methodological factors that affect research on MCI cognitive rehabilitation
- Critique the efficacy of various approaches to MCI cognitive rehabilitation
- Describe next generation cognitive interventions for MCI patients
Dr. Anthony Y. Stringer is Professor of Rehabilitation Medicine at Emory University and is the Director of the Emory Division of Rehabilitation Neuropsychology. Dr. Stringer earned his doctorate at Wayne State University, completed internship at Lafayette Clinic in Detroit, MI, and did his fellowship in clinical neuropsychology at the University of Florida. He has been board certified since 2004, and was the first African American neuropsychologist to gain certification. Dr. Stringer is a past president of the American Board of Clinical Neuropsychology and is a Fellow of the American Psychological Association (Division 40/Society for Clinical Neuropsychology) and of the National Academy of Neuropsychology. Dr. Stringer has authored or edited books on neuropsychological diagnosis and the history of neuropsychology, and has published a number of articles, abstracts, and book chapters from his research on neuropsychological syndromes and cognitive rehabilitation outcome. He is the author of the Ecologically-Oriented Neurorehabilitation of Memory and Executive Function programs.
Dr. Benjamin M. Hampstead is a board-certified Clinical Neuropsychologist who earned his PhD in Clinical Psychology (Neuropsychology emphasis) from Drexel University. He is a Professor of Psychiatry at the University of Michigan, Staff Neuropsychologist in the VA Ann Arbor Healthcare System, and Clinical Core Leader of the NIA funded Michigan Alzheimer’s Disease Research Center. Dr. Hampstead’s research focuses on non-pharmacologic approaches to maximize cognitive functioning in older adults across the dementia spectrum. Specifically, he uses cognition oriented treatments and non-invasive brain stimulation to enhance cognition, typically within the context of a randomized controlled trial format. Dr. Hampstead integrates these techniques with functional and structural neuroimaging in order to predict treatment response, identify the neuroplastic changes following treatment, and plan/develop new interventions. Ongoing work integrates amyloid and tau positron emission tomography (PET) in order to better characterize participant characteristics associated with treatment response. He has maintained continuous federal funding for his work since earning his doctorate (14+ years), with most support from the Department of Veterans Affairs and National Institute on Aging.
Dr. Margo Adams Larsen is a Research Director at Virtually Better. She received her master’s and doctorate degrees in clinical psychology from Western Michigan University and her undergraduate degrees from the University of North Dakota. She completed her pre-doctoral internship at Children’s Hospital, Inc., Columbus, now Nationwide Children’s Hospital. After graduate training, Dr. Adams Larsen completed post-doctoral psychology residency in full-time practice in Grand Forks, ND. She is licensed as a psychologist in North Dakota. She has since gone on to hold positions in the Department of Psychology and the University of North Dakota, and as a clinical research associate at the Center for Health Promotion & Prevention Research at the University of North Dakota School of Medicine and Health Sciences, while continuing to practice part-time.
Prior to joining VBI, she had a full time pediatric psychology practice implementing evidence-based techniques to address anxiety, depression, and general behavioral concerns, as well as conducting neuropsychological and behavioral assessments. She has specialized training in behavior analysis and the early intervention for autism spectrum disorders. Dr. Adams Larsen has a growing interest in the use of technology in practice, and has served on several governmental and regulatory boards, including the Joint APA/ASPPB/APAIT Taskforce on Telepsychology. Dr. Adams Larsen presents nationally about telepractice and regulatory issues.